NASDAQ : KROS
Keros Therapeutics, Inc. — Reports
Healthcare · Biotechnology · United States
Last price 11.36 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 225.24M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports